Lead Optimization in Discovery Drug Metabolism and Pharmacokinetics/Case study: The Hepatitis C Virus (HCV) Protease Inhibitor SCH 503034
K. Cheng, Walter A. Korfmacher, Ronald E. White, F. Njoroge
Perspectives in Medicinal Chemistry